Toronto Heart Centre
Toronto, Ontario, Canada
Medical clinic in Toronto, Ontario
2300 Yonge St #906, Toronto, ON M4P 1E4
About Toronto Heart Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Eidos Therapeutics, a BridgeBio company
2
Clinical Trials at Toronto Heart Centre
During the past decade, Toronto Heart Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
2018-03-20
2019-10-09
Completed
315
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
2018-03-20
2019-10-07
Completed
312
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
2019-03-19
2023-05-01
Active, not recruiting
510
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
2021-10-27
2028-05-15
Enrolling by invitation
545
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Toronto Heart Centre"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Toronto Heart Centre
According to Clinical.Site data, the most researched conditions in "Toronto Heart Centre" are
"Heart Failure" (2 trials), "Amyloid Cardiomyopathy" (1 trials), "Amyloidosis" (1 trials), "Cardiomyopathies" (1 trials) and "Heart Diseases" (1 trials). Many other conditions were trialed in "Toronto Heart Centre" in a lesser frequency.
Clinical Trials Intervention Types at Toronto Heart Centre
Most popular intervention types in "Toronto Heart Centre" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "Acoramidis (AG10)" (1 trials), "Placebo Oral Tablet" (1 trials) and "acoramidis" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Toronto Heart Centre
The vast majority of trials in "Toronto Heart Centre" are
4 trials for "All" genders.
Clinical Trials Status at Toronto Heart Centre
Currently, there are NaN active trials in "Toronto Heart Centre".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 2 completed trials in Toronto Heart Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Toronto Heart Centre, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".